These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones. Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118 [TBL] [Abstract][Full Text] [Related]
11. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies. Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and Le Y; Gan Y; Fu Y; Liu J; Li W; Zou X; Zhou Z; Wang Z; Ouyang G; Yan L J Enzyme Inhib Med Chem; 2020 Dec; 35(1):555-564. PubMed ID: 31967481 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors. Mowafy S; Farag NA; Abouzid KA Eur J Med Chem; 2013 Mar; 61():132-45. PubMed ID: 23142066 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study. El-Sayed MA; El-Husseiny WM; Abdel-Aziz NI; El-Azab AS; Abuelizz HA; Abdel-Aziz AA J Enzyme Inhib Med Chem; 2018 Dec; 33(1):199-209. PubMed ID: 29251017 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones. Abdel Gawad NM; Georgey HH; Youssef RM; El-Sayed NA Eur J Med Chem; 2010 Dec; 45(12):6058-67. PubMed ID: 21051122 [TBL] [Abstract][Full Text] [Related]
17. Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors. Alsaid MS; Al-Mishari AA; Soliman AM; Ragab FA; Ghorab MM Eur J Med Chem; 2017 Dec; 141():84-91. PubMed ID: 29028534 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysis. El-Azab AS; Abdel-Aziz AA; AlSaif NA; Alkahtani HM; Alanazi MM; Obaidullah AJ; Eskandrani RO; Alharbi A Bioorg Chem; 2020 Nov; 104():104345. PubMed ID: 33142413 [TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects. Zayed MF; Ahmed S; Ihmaid S; Ahmed HEA; Rateb HS; Ibrahim SRM Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891789 [TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis and Antitumor Activities of Novel Quinazolinone Derivatives as Potential EGFR Inhibitors. Wang J; Huang L; Chen X; Yuan Y; Sun J; Yang M Chem Pharm Bull (Tokyo); 2022; 70(9):637-641. PubMed ID: 36047235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]